Frank Pistrosch
Department of Medicine
Technical University of Dresden
Dresden
Germany
Name/email consistency: high
- Effects of the alpha glucosidase inhibitor acarbose on endothelial function after a mixed meal in newly diagnosed type 2 diabetes. Pistrosch, F., Schaper, F., Passauer, J., Koehler, C., Bornstein, S.R., Hanefeld, M. Horm. Metab. Res. (2009)
- Ambulatory blood pressure vs. office blood pressure in type 2 diabetes. Pistrosch, F. Am. J. Hypertens. (2008)
- Relationship between diurnal blood pressure variation and diurnal blood glucose levels in type 2 diabetic patients. Pistrosch, F., Reissmann, E., Wildbrett, J., Koehler, C., Hanefeld, M. Am. J. Hypertens. (2007)
- An old patient with end stage renal disease and sudden onset of confusion and lethargy. Pistrosch, F., Büssemaker, E., Gross, P. Nephrol. Dial. Transplant. (2006)
- Relationship between diurnal glucose levels and HbA1c in type 2 diabetes. Pistrosch, F., Koehler, C., Wildbrett, J., Hanefeld, M. Horm. Metab. Res. (2006)
- PPARgamma-agonist rosiglitazone increases number and migratory activity of cultured endothelial progenitor cells. Pistrosch, F., Herbrig, K., Oelschlaegel, U., Richter, S., Passauer, J., Fischer, S., Gross, P. Atherosclerosis (2005)
- Rosiglitazone improves glomerular hyperfiltration, renal endothelial dysfunction, and microalbuminuria of incipient diabetic nephropathy in patients. Pistrosch, F., Herbrig, K., Kindel, B., Passauer, J., Fischer, S., Gross, P. Diabetes (2005)
- In type 2 diabetes, rosiglitazone therapy for insulin resistance ameliorates endothelial dysfunction independent of glucose control. Pistrosch, F., Passauer, J., Fischer, S., Fuecker, K., Hanefeld, M., Gross, P. Diabetes. Care (2004)